首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Self-assembly of pH-responsive biodegradable mixed micelles based on anionic and cationic polycarbonates for doxorubicin delivery
【24h】

Self-assembly of pH-responsive biodegradable mixed micelles based on anionic and cationic polycarbonates for doxorubicin delivery

机译:基于阴离子和阳离子聚碳酸酯的pH响应性可生物降解混合胶束的自组装,用于阿霉素的递送

获取原文
获取原文并翻译 | 示例
           

摘要

Poly(5-propyl-1,3-dioxan-2-one)-b-dimethylamine modified polycarbonate (PC(MPpC-MMA)) and poly(ethylene glycol)-b-carboxylated polycarbonate (PEG-PCCOOH) diblock copolymers were prepared to construct a pH responsive, highly stable and biodegradable mixed micelle. The two copolymers self assembled into the mixed micelle in pH 7.4 PBS driven by electrostatic and hydrophobic interactions. PC(MPpC-MMA) with hydrophobic inner core was used for carrying drug and the dimethylamine part was designed as a trigger to disassemble the mixed micelle. PEG-PCCOOH could shield the positive character of the micelle which might show disadvantage to normal tissue. In addition, the free carboxyl groups could further increase the loading efficiency of positive charged drugs. The size and zeta potential of the micelle gradually decreased with increasing the molar ratio of PEG-PCCOOH to PC(MPpC-MMA). These mixed micelles could withstand high ionic strength of plasma and were rather stable for long time storage. However, via decrease of pH value from 7.4 to 5.0, they could undergo dissociation into smaller nanoparticles which were in a diameter of 20 nm and showed positive surface nature. In vitro drug delivery studies showed a faster release rate at pH 5.0 than that at pH 7.4. The KIT assays demonstrated potent cytotoxic activity against HepG2 cells. All these results indicate that the newly mixed polycarbonate micelle can show great potential in biomedical field. (C) 2016 Elsevier B.V. All rights reserved.
机译:制备了聚(5-丙基-1,3-二恶烷-2-酮)-b-二甲胺改性的聚碳酸酯(PC(MPpC-MMA))和聚(乙二醇)-b-羧化聚碳酸酯(PEG-PCCOOH)二嵌段共聚物来构建pH响应,高度稳定和可生物降解的混合胶束。两种共聚物在静电和疏水相互作用的驱动下,在pH 7.4 PBS中自组装成混合胶束。使用具有疏水性内核的PC(MPpC-MMA)携带药物,并设计了二甲胺部分作为引发剂来分解混合胶束。 PEG-PCCOOH可以掩盖胶束的阳性特征,这可能对正常组织不利。另外,游离羧基可以进一步增加带正电荷的药物的负载效率。随着PEG-PCCOOH与PC(MPpC-MMA)的摩尔比的增加,胶束的大小和ζ电势逐渐减小。这些混合的胶束可以承受等离子体的高离子强度,并且对于长时间存储而言相当稳定。但是,通过将pH值从7.4降低到5.0,它们可以解离成直径为20 nm的较小纳米颗粒,并显示出正的表面性质。体外药物递送研究显示,在pH 5.0时的释放速率比在pH 7.4时更快。 KIT分析显示出对HepG2细胞有效的细胞毒活性。所有这些结果表明,新混合的聚碳酸酯胶束在生物医学领域具有巨大的潜力。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号